Form 4: Clorox Director Amy Banse Acquires Shares and Deferred Stock Units

Director Amy Banse increased her holdings in Clorox through the acquisition of common stock and deferred stock units.

Summary

• On September 30, 2024, Amy Banse, a director of Clorox, acquired 161 shares of common stock at a price of $162.91 per share.
• Following this transaction, Banse directly owns 524 shares of Clorox common stock.
• Additionally, on August 30, 2024, Banse acquired 61.4205 deferred stock units through dividend reinvestment.
• These deferred stock units will be settled in Clorox stock upon her retirement or termination of service as a director.
• After the transaction, Banse holds 8,031.4878 deferred stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by a director. The acquisition of shares could be seen as a slightly positive signal, but it's not a major event.

Positives

• Director's acquisition of shares may signal confidence in the company's future performance.

Future Outlook

The deferred stock units will be settled 100% in Clorox stock upon the director's retirement or termination of service.

Industry Context

Tracking insider transactions provides insights into management's perspective on the company's valuation and future prospects relative to the broader consumer goods industry.

Comparison to Industry Standards

• Comparing insider trading activity at Clorox to similar companies like Procter & Gamble (PG) or Unilever (UL) can provide a benchmark for assessing management's confidence.
• For example, if executives at P&G or Unilever are also increasing their holdings, it could signal a positive outlook for the consumer staples sector as a whole.

Stakeholder Impact

• The director's stock acquisition could have a minor positive impact on shareholder sentiment.

Key Dates